
Financial Data and Key Metrics Changes - The company delivered 2.2% organic sales growth with a real internal growth (RIG) of 0.8% and pricing of 1.5% [11] - Gross profit margin increased by 80 basis points, while the UTOP margin was 17%, down 10 basis points compared to 2023 [15][18] - Free cash flow improved by CHF 0.9 billion to CHF 10.7 billion, driven by a reduction in working capital, lower tax, and lower cash restructuring costs [35] Business Line Data and Key Metrics Changes - Zone North America experienced disappointing growth, particularly in frozen food and coffee creamers, but improved UTOP margin through mix management and cost control [22][23] - Zone Europe showed solid growth with improving market share trends, while Zone AOA delivered positive RIG despite macro headwinds [24] - Nestlé Health Science saw accelerated growth in the second half of the year, with market share trends improving in VMS [27] Market Data and Key Metrics Changes - Consumer demand softened in 2024, particularly in Zone AOA, impacting organic growth negatively [12] - The company faced challenges in the U.S. market, particularly in frozen food and coffee creamers, while Latin America saw growth driven by pricing [25][29] - In China, a deflationary environment limited pricing opportunities, but the zone still delivered solid RIG-led growth [26] Company Strategy and Development Direction - The company is stepping up investment to accelerate category growth and improve market share performance, funded by a CHF 2.5 billion cost savings program called Fuel for Growth [5][9] - The organization has been simplified, moving from five zones to three, and digital and sustainability initiatives are now reported directly to the CEO [40][41] - The company aims for mid-term growth of over 4% and is focusing on expanding winners, achieving more impact from innovation, and addressing underperformance [55] Management's Comments on Operating Environment and Future Outlook - Management noted that consumer sentiment remains fragile, but actions taken to reduce customer inventories and improve competitiveness are expected to benefit future growth [12][22] - The company expects organic sales growth to improve in 2025, with UTOP margin projected to be at or above 16% [72] - Management acknowledged that gross margins are expected to be lower due to ongoing commodity price inflation, particularly in coffee and cocoa [123] Other Important Information - The company delivered over CHF 1.2 billion of efficiencies in 2024, with CHF 500 million coming from recipe reformulation [18] - The net debt-to-EBITDA ratio is towards the top end of the range, reflecting improvements in working capital and lower restructuring costs [37] - The company is committed to creating shared value and is ahead of schedule on targets related to greenhouse gas reduction and regenerative agriculture [68] Q&A Session All Questions and Answers Question: Pricing and Volume Impact - The company acknowledged the need for pricing actions due to higher commodity costs and discussed the potential impact on volumes, indicating a commitment to return to positive volume growth in 2025 [75][78] Question: PetCare Growth Visibility - Management expressed optimism about the PetCare category, highlighting ongoing pet adoption trends and the potential for growth in emerging markets [84][86] Question: Q1 Performance Expectations - Management indicated that Q1 may experience technical factors affecting performance, but overall growth is expected to improve throughout the year [90][94] Question: COGS Inflation and Margin Guidance - The company expects high single-digit inflation in COGS and indicated that gross margins would be lower due to not fully recovering cost inflation through pricing and efficiencies [97][123] Question: Innovation Plans for 2025 - Management highlighted ongoing innovation efforts, particularly in coffee and pet care, and emphasized the importance of strengthening value propositions to address underperformance [124][126]